Matsui K, Miyawaki Y, Suzuki Y, Furube T, et al. Relationship between immune-related adverse events and long-term survival in patients treated with immune checkpoint inhibitors for unresectable advanced or recurrent esophageal cancer. Dis Esophagus 2026;39:doag036.
PMID: 42001475